She also welcomed the subsidies, saying previous studies had identified cost as one of the biggest barriers to genetic testing.
“When there is a cost to a test, we have unintended consequences,” she said, pointing out that patients who can afford the test would have the information and ability to undertake preventive measures, whereas those who are unable to afford it would be left out.
Read Full Article At Source


